Pre-diabetic biomarker ID'd at Virginia Tech; Karolinska researchers highlight immuno-oncology targets

> Virginia Tech researchers say they identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes. Release

> A study by researchers at Sweden's Karolinska Institutet says that cells in tumor blood vessels protect cancer cells from tumor-killing immune cells. Release

> Scientists at the University of Bonn showed how the body provides killer cells with a helper in the case of an infection. Release

> An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.